Stereotactic Ablative Radiotherapy (SABR) for Low Risk Prostate Cancer With Injectable Rectal Spacer
NCT02353832
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DEVICE:
Injectable Rectal Spacer (SpaceOAR, Duraseal or equivalent)
Sponsor
University of Texas Southwestern Medical Center